Innovation
2 patent families (1 granted) — focus: Human necessities; filing pace slowing. Cited 55 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |
Develop treatments for cardiovascular diseases related to dyslipidemia
2 patent families (1 granted) — focus: Human necessities; filing pace slowing. Cited 55 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |